Empagliflozin Is Safe and Effective in Patients With Chronic Kidney Disease
The EMPA-KIDNEY trial results were presented at the American Society of Nephrology Kidney Week 2022. George Thomas, MD, site director for Cleveland Clinic, discusses key takeaways.
consultqd.clevelandclinic.org